Correspondence: When an article is eligible for submission of
Correspondence, a link to the response form is available within the full-text
article. You must be a
current subscriber who has activated the online portion of your subscription
in order to send a Correspondence. Any reader can read published
Correspondence.
Correspondence to:
ARTICLES:
H. Tada, J. Takanashi, A. J. Barkovich, H. Oba, M. Maeda, H. Tsukahara, M. Suzuki, T. Yamamoto, T. Shimono, T. Ichiyama, T. Taoka, O. Sohma, H. Yoshikawa, and Y. Kohno
Clinically mild encephalitis/encephalopathy with a reversible splenial lesion
Neurology 2004; 63: 1854-1858
[Abstract][Full text][PDF]
jtaka{at}faculty.chiba-u.jp Jun-ichi Takanashi, et al.
We thank Shiihara et al for their interesting comments concerning the
possible role of mitochondrial dysfunction and elevation of inflammatory
cytokines in the generation of the splenial lesions. In 15 patients in our
study, IL-6 was measured in one patient (patient 2), showing mild
elevation of IL-6 (11.5 pg/ml, normal less than 9.7). [1] Lactate in blood or
CSF was normal in the three patients so examined (patients 10 and 15 in
reference 1; patient 1 in reference 6). IL-6 or other inflammatory
cytokines are usually elevated in influenza-associated
encephalitis/encephalopathy, in parallel with clinical severity. [7] But a
reversible splenial lesion was rarely observed in a few clinically mild
cases of influenza-associated encephalopathy. [1,6]
Therefore, we believe it
is unlikely that elevation of IL-6 plays a direct role in the pathogenesis
of the splenial lesion. It will be interesting to see whether
mitochondrial dysfunction or lactate elevation in the splenium, or
elevation of cytokines in CSF are present in patients with splenial
lesions in the future.
We thank Dr. Doherty et al for adding this interesting data and
observations. We agree that patients with a reversible splenial lesion
rarely present with neurological findings of hemispheric disconnection.
We could not find any clinical evidence of hemispheric
disconnection in our 15 patients. [1] Perhaps most of the patients presented with disorders of consciousness,
thus neurological examination could not be fully assessed, especially in
association with the young age of the affected patients.
The patients in our study were reviewed retrospectively.
We excluded a
patient taking oral antiepileptic drugs because of another potential cause
for the splenial lesion. This bias of the enrolled patients might explain
the high frequency of disorders of consciousness.
We do not know what role or roles the splenium may play in
moderating encephalopathy, confusion or delirium.
References
6. Takanashi J, Barkovich AJ, Yamaguchi K, Kahno Y. Influenza
encephalopathy with a reversible lesion in the splenium of the corpus
callosum. AJNR Am J Neuroradiol 2004; 25: 798-802.
7. Aiba H, Mochizuki M, Kimura M, Hojo H. Predictive value of serum
interleukin-6 level in influenza virus-associated encephalopathy.
Neurology 2001; 57: 295-299.
Clinically mild encephalitis/encephalopathy with a reversible splenial lesion
27 December 2004
Michael J Doherty, Swedish Neuroscience Institute and the University of Washington Department of Neurology 801 Broadway Suite 901, Seattle, WA 98122, Nate F. Watson, Sumi Jayadev, Ravi S Konchada, Dan K Hallam
michael.doherty{at}swedish.org Michael J Doherty, et al.
Tada et al reported clinical scenarios where
MRI-evident midline splenium lesions are seen, particularly with diffusion
weighted images (DWI).[1] We recently reviewed nine similar cases of MRI-evident splenium changes along with 48 other reported cases.[2]
It is surprising that
the bulk of the cases with splenium injury do not show clinical evidence of
hemispheric disconnection (apraxias of the left hand, pseudoneglect, alien
left hand, astereognosis, agraphia, alexia, visual apraxias, hemaniopsia
etc.) Of 57 cases examined, 25% had findings suggestive of
disconnection. The most common finding (60% of patients) was delirium,
confusion, agitation or encephalopathy.
Tada et al's study suggests a similar
percentage (8/15 "encephalopathic" with 4 additional patients described as
"delirious" i.e. 80%). It is interesting that such poorly localizable
clinical findings as "delirium", "encephalopathy", "confusion" or
"agitation" might be associated with a consistent, very discrete, and
small radiological finding.
Could the authors speculate on what roles the
splenium may play in moderating encephalopathy, confusion or delirium? Furthermore, did they find a similarly low percentage of neurological
findings of hemispheric disconnection?
References
1) Tada H, Takanashi J, Barkovich AJ, et al.
Clinically mild encephalitis/encephalopathy with a reversible splenial
lesion Neurology 2004 63: 1854-1858.
2) Doherty MJ, Jayadev S, Konchada R, Hallam D, Watson NF. What clinical
implications might splenium damage have? Archives of Neurology, 2005 (in
press).
Clinically mild encephalitis/encephalopathy with a reversible splenial lesion
27 December 2004
Takashi Shiihara, Department of Pediatrics, Yamagata University School of Medicine 2-2-2 Iida-nishi, Yamagata, 990-9585, Japan, Mitsuhiro Kato, Kiyoshi Hayasaka,
shiihara{at}med.id.yamagata-u.ac.jp Takashi Shiihara, et al.
Tada et al [1] reported patients with encephalitis/encephalopathy
showing a reversible splenial lesion and an excellent prognosis. The
etiology is heterogeneous and includes seizures or antiepileptic drugs as
well as viral infections. We report a patient with a reversible splenial
lesion, who demonstrated a mitochondrial DNA mutation as well as CSF
cytokine elevation and discuss the pathological mechanism.
The 16 year-old patient was the third child of healthy non-consanguineous parents. She had mild neuropathy with foot deformity and muscle
weakness after infancy. She also had intercurrent dizziness.
Muscle biopsy demonstrated a normal histology but also showed a
mitochondrial DNA mutation 8993 T>G. She hardly walked after three
weeks of diarrhea but there was no change in serum electrolytes or motor
nerve conduction studies. Brain MRI after 4 days showed an isolated ovoid
lesion in the central portion of the splenium of the corpus callosum. CSF
examinations demonstrated elevations of lactate and interleukin-6 (IL-6)
to 27.8 mg/dl and 66.4 (normal <9.7) pg/ml. Specific
pathogen was not identified on cultures, PCR or antibody assays. The
splenial lesion completely disappeared after 8 days and gait disturbance
was recovered within a month.
The mitochondrial DNA mutation 8993 T>G is located within the gene
for adenosine triphosphate (ATP) synthase subunit 6 and would decrease the
capacity for ATP synthesis. [2] In addition, IL-6 directly inhibits ATP
synthesis and limits the mitochondrial energy supply. [3] However, 5-
fluorouracil is known to cause leukoencephalopathy with a splenial lesion
and lactic acidosis. [4] Derivatives of 5-fluorouracil inhibit the activity
of aconitase, which converts citrate to isocitrate, resulting in a
malfunction of the tricarboxylic acid cycle. [5] Taken together, the
mitochondrial dysfunction induced by the CNS cytokine elevation could play
a key role in the splenial lesion seen in our patient.
We suggest that
studies of cytokines or mitochondrial functions, such as lactate or
magnetic resonance spectroscopy, would clarify the pathogenesis of such splenial lesions.
References
1. Tada H, Takanashi J, Barkovich AJ, et al. Clinically mild encephalitis/encephalopathy with a reversible splenial
lesion. Neurology 2004;63: 1854
2. Nijtmans LG, Henderson NS, Attardi G, Holt IJ. Impaired ATP synthase
assembly associated with a mutation in the human ATP synthase subunit 6
gene. J Biol Chem 2001;276:6755-6762.
3. Berthiaume F, MacDonald AD, Kang YH, Yarmush ML. Control analysis of
mitochondrial metabolism in intact hepatocytes: effect of interleukin-
1beta and interleukin-6. Metab Eng 2003;5:108-123
4. Tha KK, Terae S, Sugiura M, et al. Diffusion-weighted magnetic resonance imaging in early stage
of 5-fluorouracil-induced leukoencephalopathy. Acta Neurol Scand.
2002;106:379-86.
5. Matsubara I, Kamiya J, Imai S.Cardiotoxic effects of 5-fluorouracil
in the guinea pig. Jpn J Pharmacol 1980;30:871-9